216 related articles for article (PubMed ID: 23911960)
1. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma.
Kubota D; Mukaihara K; Yoshida A; Tsuda H; Kawai A; Kondo T
J Proteomics; 2013 Oct; 91():393-404. PubMed ID: 23911960
[TBL] [Abstract][Full Text] [Related]
2. Peroxiredoxin 2 as a chemotherapy responsiveness biomarker candidate in osteosarcoma revealed by proteomics.
Kikuta K; Tochigi N; Saito S; Shimoda T; Morioka H; Toyama Y; Hosono A; Suehara Y; Beppu Y; Kawai A; Hirohashi S; Kondo T
Proteomics Clin Appl; 2010 May; 4(5):560-7. PubMed ID: 21137073
[TBL] [Abstract][Full Text] [Related]
3. Expression profiles of osteosarcoma that can predict response to chemotherapy.
Man TK; Chintagumpala M; Visvanathan J; Shen J; Perlaky L; Hicks J; Johnson M; Davino N; Murray J; Helman L; Meyer W; Triche T; Wong KK; Lau CC
Cancer Res; 2005 Sep; 65(18):8142-50. PubMed ID: 16166288
[TBL] [Abstract][Full Text] [Related]
4. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
He L; Yang H; Huang J
BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
[TBL] [Abstract][Full Text] [Related]
5. An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.
Mintz MB; Sowers R; Brown KM; Hilmer SC; Mazza B; Huvos AG; Meyers PA; Lafleur B; McDonough WS; Henry MM; Ramsey KE; Antonescu CR; Chen W; Healey JH; Daluski A; Berens ME; Macdonald TJ; Gorlick R; Stephan DA
Cancer Res; 2005 Mar; 65(5):1748-54. PubMed ID: 15753370
[TBL] [Abstract][Full Text] [Related]
6. Correlation between ERK1 and STAT3 expression and chemoresistance in patients with conventional osteosarcoma.
Salas S; Jiguet-Jiglaire C; Campion L; Bartoli C; Frassineti F; Deville JL; Maues De Paula A; Forest F; Jézéquel P; Gentet JC; Bouvier C
BMC Cancer; 2014 Aug; 14():606. PubMed ID: 25146150
[TBL] [Abstract][Full Text] [Related]
7. Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance.
Sero V; Tavanti E; Vella S; Hattinger CM; Fanelli M; Michelacci F; Versteeg R; Valsasina B; Gudeman B; Picci P; Serra M
Invest New Drugs; 2014 Dec; 32(6):1167-80. PubMed ID: 25193492
[TBL] [Abstract][Full Text] [Related]
8. Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells.
Serritelli EN; Sartini D; Campagna R; Pozzi V; Martin NI; van Haren MJ; Salvolini E; Cecati M; Rubini C; Emanuelli M
Eur J Clin Invest; 2024 Jun; 54(6):e14185. PubMed ID: 38426563
[TBL] [Abstract][Full Text] [Related]
9. CPNE1 silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells.
Jiang Z; Jiang J; Zhao B; Yang H; Wang Y; Guo S; Deng Y; Lu D; Ma T; Wang H; Wang J
Oncol Rep; 2018 Feb; 39(2):643-650. PubMed ID: 29207139
[TBL] [Abstract][Full Text] [Related]
10. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
Li X; Xu R; Liu H; Fang K
Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells.
Zhou X; Natino D; Zhai X; Gao Z; He X
Mol Med Rep; 2018 May; 17(5):7209-7217. PubMed ID: 29568877
[TBL] [Abstract][Full Text] [Related]
12. CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma.
Iwata S; Tatsumi Y; Yonemoto T; Araki A; Itami M; Kamoda H; Tsukanishi T; Hagiwara Y; Kinoshita H; Ishii T; Nagase H; Ohira M
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036394
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA
Lee AM; Ferdjallah A; Moore E; Kim DC; Nath A; Greengard E; Huang RS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681828
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin 1 (PRDX1) Suppresses Progressions and Metastasis of Osteosarcoma and Fibrosarcoma of Bone.
Wang Y; Liu M; Yang P; Peng H
Med Sci Monit; 2018 Jun; 24():4113-4120. PubMed ID: 29908016
[TBL] [Abstract][Full Text] [Related]
16. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
17. Targeting Clusterin Induces Apoptosis, Reduces Growth Ability and Invasion and Mediates Sensitivity to Chemotherapy in Human Osteosarcoma Cells.
Wang X; Yu Y; Zang L; Zhang P; Ma J; Chen D
Curr Pharm Biotechnol; 2020; 21(2):131-139. PubMed ID: 31433751
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2.
Salas S; Jézéquel P; Campion L; Deville JL; Chibon F; Bartoli C; Gentet JC; Charbonnel C; Gouraud W; Voutsinos-Porche B; Brouchet A; Duffaud F; Figarella-Branger D; Bouvier C
Int J Cancer; 2009 Aug; 125(4):851-60. PubMed ID: 19449377
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived osteosarcoma cells are resistant to methotrexate.
Dos Santos Cavalcanti A; Meohas W; Ribeiro GO; de Sá Lopes AC; Gholamin S; Razavi M; Hanae Kasai Brunswick T; Avan A; Matheus Guimarães JA; Leite Duarte ME; Kahn SA
PLoS One; 2017; 12(9):e0184891. PubMed ID: 28934267
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
